GLP-1 Receptor Agonist Use and Risk of Suicide Death
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Internal Medicine"
DOI: 10.1001/jamainternmed.2024.4369
Abstract: This cohort study assesses the association between use of glucagon-like peptide-1 receptor agonists and the risk of suicide death in routine clinical practice. read more here.
Keywords: suicide death; risk suicide; use; glp receptor ... See more keywords
Characterizing GLP-1 Receptor Agonist Use in Preadolescent and Adolescent Populations
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.39887
Abstract: This cross-sectional study examines the characteristics of preadolescent and adolescent populations who received glucagon-like peptide-1 (GLP-1) receptor agonists. read more here.
Keywords: adolescent populations; glp receptor; preadolescent adolescent; characterizing glp ... See more keywords
GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2025.26321
Abstract: This cohort study examines the occurrence of diabetic retinopathy, ischemic optic nerve disease, or other ocular complications within 2 years of glucagon-like peptide-1 receptor agonist (GLP-1 RA) use among patients with type 2 diabetes. read more here.
Keywords: patients type; receptor agonists; type diabetes; glp receptor ... See more keywords
GLP-1 Receptor Agonists for Pharmacologically Induced Weight Gain.
Sign Up to like & getrecommendations! Published in 2025 at "JAMA psychiatry"
DOI: 10.1001/jamapsychiatry.2025.2536
Abstract: This Viewpoint discusses the use of glucagon-like peptide-1 (GLP-1) receptor agonists as a strategy to manage psychotropic-induced weight gain. read more here.
Keywords: glp receptor; receptor agonists; weight gain; induced weight ... See more keywords
GLP‐1 receptor agonist use during hospitalisation: Better glycaemic control compared to premixed insulin
Sign Up to like & getrecommendations! Published in 2022 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3574
Abstract: Glycaemic control associates with better outcomes for hospitalised patients. Whether GLP‐1 receptor agonists (GLP‐1 RA) are suitable and effective drugs for inpatients is unclear. read more here.
Keywords: glycaemic control; glp receptor; agonist use; receptor agonist ... See more keywords
The GLP‐1 receptor agonist liraglutide protects against oxidized LDL‐induced endothelial inflammation and dysfunction via KLF2
Sign Up to like & getrecommendations! Published in 2019 at "IUBMB Life"
DOI: 10.1002/iub.2046
Abstract: Cardiovascular complications are the major causes of the mortality and morbidities in diabetic patients. The diabetic patients have an increased risk of developing atherosclerosis, which could lead to heart attack and stroke. Glucagon‐like peptide 1… read more here.
Keywords: glp receptor; ldl induced; klf2;
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study
Sign Up to like & getrecommendations! Published in 2021 at "Diabetologia"
DOI: 10.1007/s00125-021-05508-1
Abstract: Concerns have been raised regarding a potential association of use of the incretin-based drugs dipeptidyl peptidase 4 (DPP4) inhibitors and glucagon-like peptide-1 (GLP-1)-receptor agonists with risk of cholangiocarcinoma. We examined this association in nationwide data… read more here.
Keywords: dpp4 inhibitors; receptor agonists; cholangiocarcinoma; glp receptor ... See more keywords
A qualitative study of the mental health outcomes in people being treated for obesity and type 2 diabetes with glucagon-like peptide-1 receptor agonists
Sign Up to like & getrecommendations! Published in 2024 at "Acta Diabetologica"
DOI: 10.1007/s00592-024-02392-0
Abstract: Obesity and type 2 diabetes (T2D) are associated with increased rates of mental disorders, particularly depression, anxiety and binge-eating disorder. GLP-1 receptor agonists are a novel class of pharmacological agents for obesity and T2D. We… read more here.
Keywords: receptor; mental health; obesity; receptor agonists ... See more keywords
GLP-1 Receptor Agonists: Encouraging Signals for Treating Alcohol Use Disorder
Sign Up to like & getrecommendations! Published in 2025 at "Journal of General Internal Medicine"
DOI: 10.1007/s11606-025-09498-3
Abstract: Excessive alcohol use is a leading cause of preventable death in the USA, and the number of annual deaths from alcohol more than doubles the number from drug overdose. As newer glucagon-like peptide-1 (GLP-1) receptor… read more here.
Keywords: use; use disorder; glp receptor; alcohol use ... See more keywords
Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain
Sign Up to like & getrecommendations! Published in 2017 at "Diabetes Therapy"
DOI: 10.1007/s13300-017-0239-6
Abstract: ABSTRACTIntroduction Glucagon-like peptide-1 (GLP-1) receptor agonists are used successfully in the treatment of patients with type 2 diabetes as they are associated with low hypoglycemia rates, weight loss and improved glycemic control. This study compared,… read more here.
Keywords: liraglutide versus; treatment; type diabetes; glp receptor ... See more keywords
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes Therapy"
DOI: 10.1007/s13300-018-0420-6
Abstract: IntroductionWhen treating type 2 diabetes, drugs that cause hypoglycemia and weight gain should, if possible, be avoided. In addition, due to the increased incidence and prevalence of cardiovascular disease, cardiac events and heart failure, as… read more here.
Keywords: combination; renal decompensation; risk; treatment ... See more keywords